Dazhuan E. Xin
320 Yueyang Road
Yueyang, 200031, China
Yueyang, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma.
Journal: Science advances
Published: July 17, 2026
A CAR-T Tonic Signaling Code Predicts Anti-Tumor Efficacy in Diffuse Midline Glioma.
Journal: Neuro-oncology
Published: January 08, 2026
Single-cell and Spatial Omics Reveals Region-Specific Plasticity and Therapeutic Vulnerabilities in Metastatic High-Risk Neuroblastoma.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
A Tonic Signaling Code Predicts CAR-T Cell Efficacy in Diffuse Midline Glioma.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Retraction Note: Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
Journal: Nature
Published: July 09, 2025
Publisher Correction: DOR activation in mature oligodendrocytes regulates α-ketoglutarate metabolism leading to enhanced remyelination in aged mice.
Journal: Nature neuroscience
Published: September 24, 2024
Zinc-Finger Protein ZFP488 Regulates the Timing of Oligodendrocyte Myelination and Remyelination.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: January 20, 2024
Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201.
Journal: Neuro-oncology
Published: November 27, 2023
DOR activation in mature oligodendrocytes regulates α-ketoglutarate metabolism leading to enhanced remyelination in aged mice.
Journal: Nature neuroscience
Published: July 20, 2023
Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Journal: Cancer research
Published: May 16, 2022
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Journal: Nature communications
Published: April 26, 2022
Last Updated: 09/26/2026